Status:

COMPLETED

Aldena STAR Particles

Lead Sponsor:

Emory University

Conditions:

Healthy

Eligibility:

All Genders

18-39 years

Phase:

NA

Brief Summary

The objective of this study is to find out the best method of applying STAR particles to the skin. STAR particles are very small particles with microneedles on the surface that can increase and create...

Detailed Description

The goal of this study is to identify the most efficacious pressure of administration and the minimum number of rubbing cycles necessary to perforate the stratum corneum (the outermost layer of the sk...

Eligibility Criteria

Inclusion

  • Adult, 18 - 39 years of age
  • In good general health as determined by a medical history
  • Willing and able to provide informed consent and follow all study requirements
  • Not pregnant and does not desire to become pregnant in the subsequent two months

Exclusion

  • Has a known allergy or sensitivity to aloe vera or alumina
  • Has any skin disorders or skin allergies
  • Has any medical condition that may affect skin or skin sensation
  • Has abnormal (e.g., tattooed) skin at forearms
  • Has known neurological condition affecting sensory function or perception of pain
  • Has inflammatory bowel disease
  • Has applied skin ointment or cream to forearms in the previous 24 hours
  • Has a major congenital or chromosomal abnormality known to affect the skin
  • Has taken pain medication in the last 24 hours
  • Is currently participating in another interventional clinical trial
  • Has previously participated in a STAR particle interventional clinical trial
  • Is pregnant or wishing to be pregnant
  • Has any condition (social or medical), which in the opinion of the investigator would make study participation unsafe, would interfere with adherence to the clinical study requirements, or would complicate data interpretation

Key Trial Info

Start Date :

February 7 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 7 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06004973

Start Date

February 7 2024

End Date

December 7 2024

Last Update

January 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory Children's Center

Atlanta, Georgia, United States, 30322